Sun Pharmaceutical Industries Ltd.

The sales moved up 27.57% to Rs. 52852.90 millions for the September 2022 quarter as compared to Rs. 41431.50 millions during the year-ago period.Net Profit recorded in the quarter ended September 2022 rise to 49.93% to Rs. 12130.10  millions  compared to R. 8090.70 millions in corresponding previous quarter.The company reported a good operating profit of 17048.80 millions compared to 11485.40 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202209	202109	% Var	202209	202109	% Var	202203	202103	% Var
Sales	52852.90	41431.50	27.57	102181.70	78084.40	30.86	155859.80	141160.50	10.41
Other Income	417.10	2842.70	-85.33	2179.20	4959.60	-56.06	11968.80	1920.70	523.15
PBIDT	17048.80	11485.40	48.44	32035.30	16035.70	99.77	38654.40	24490.80	57.83
Interest	927.70	1039.80	-10.78	1798.40	2114.40	-14.95	3881.00	2675.20	45.07
PBDT	16121.10	10445.60	54.33	30236.90	12265.60	146.52	16568.10	20920.00	-20.80
Depreciation	3839.50	3336.40	15.08	7584.50	6405.70	18.40	13499.50	12364.30	9.18
PBT	12281.60	7109.20	72.76	22652.40	5859.90	286.57	3068.60	8555.70	-64.13
TAX	151.50	-981.50	-115.44	404.30	-848.00	-147.68	4068.50	131.70	2989.22
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	12130.10	8090.70	49.93	22248.10	6707.90	231.67	-999.90	8424.00	-111.87
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	32.26	27.72	16.36	31.35	20.54	52.66	24.80	17.35	42.95